Mortimer Gierthmuehlen

Prof. Dr. Mortimer Gierthmuehlen

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2014 in Journal of Neural Engineering
Verified
Journal Article
Closed access
DPDennis T T Plachta
Dennis T T Plachta
MGMortimer Gierthmuehlen
Mortimer Gierthmuehlen
OCOscar Cota
Oscar Cota
NENayeli Espinosa
Nayeli Espinosa
FBFabian Boeser
Fabian Boeser
JZJoseph Zentner
Joseph Zentner
Hypertension is the largest threat to patient health and a burden to health care systems. Despite various options, 30% of patients do not respond sufficiently to medical treatment. Mechanoreceptors in the aortic arch relay blood pressure (BP) levels through vagal nerve (VN) fibers to the brainstem and trigger the baroreflex, lowering the BP. Selective electrical stimulation of these nerve fibers reduced BP in rats. However, there is no technique described to localize and stimulate these fibers inside the VN without inadvertent stimulation of non-baroreceptive fibers causing side effects like bradycardia and bradypnea. We present a novel method for selective VN stimulation to reduce BP without the aforementioned side effects. Baroreceptor compound activity of rat VN (n = 5) was localized using a multichannel cuff electrode, true tripolar recording and a coherent averaging algorithm triggered by BP or electrocardiogram. Tripolar stimulation over electrodes near the barofibers reduced the BP without triggering significant bradycardia and bradypnea. The BP drop was adjusted to 60% of the initial value by varying the stimulation pulse width and duration, and lasted up to five times longer than the stimulation. The presented method is robust to impedance changes, independent of the electrode's relative position, does not compromise the nerve and can run on implantable, ultra-low power signal processors.

30 March 2018 in Neurosurgery
Verified
Journal Article
Open access
PDF file
JHJohn David Heiss
John David Heiss
KJKatie Jarvis
Katie Jarvis
RSRené K Smith
René K Smith
EEEric Eskioglu
Eric Eskioglu
MGMortimer Gierthmuehlen
Mortimer Gierthmuehlen
EOEdward H Oldfield
Edward H Oldfield
BACKGROUND: The origin of syrinx fluid is controversial. OBJECTIVE: To elucidate the mechanisms of syringomyelia associated with cerebrospinal fluid pathway obstruction and with intramedullary tumors, contrast transport from the spinal subarachnoid space (SAS) to syrinx was evaluated in syringomyelia patients. METHODS: We prospectively studied patients with syringomyelia: 22 with Chiari I malformation and 16 with SAS obstruction-related syringomyelia before and 1 wk after surgery, and 9 with tumor-related syringomyelia before surgery only. Computed tomography-myelography quantified dye transport into the syrinx before and 0.5, 2, 4, 6, 8, 10, and 22 h after contrast injection by measuring contrast density in Hounsfield units (HU). RESULTS: Before surgery, more contrast passed into the syrinx in Chiari I malformation-related syringomyelia and spinal obstruction-related syringomyelia than in tumor-related syringomyelia, as measured by (1) maximum syrinx HU, (2) area under the syrinx concentration-time curve (HU AUC), (3) ratio of syrinx HU to subarachnoid cerebrospinal fluid (CSF; SAS) HU, and (4) AUC syrinx/AUC SAS. More contrast (AUC) accumulated in the syrinx and subarachnoid space before than after surgery. CONCLUSION: Transparenchymal bulk flow of CSF from the subarachnoid space to syrinx occurs in Chiari I malformation-related syringomyelia and spinal obstruction-related syringomyelia. Before surgery, more subarachnoid contrast entered syringes associated with CSF pathway obstruction than with tumor, consistent with syrinx fluid originating from the subarachnoid space in Chiari I malformation and spinal obstruction-related syringomyelia and not from the subarachnoid space in tumor-related syringomyelia. Decompressive surgery opened subarachnoid CSF pathways and reduced contrast entry into syringes associated with CSF pathway obstruction.

27 March 2017 in Brain-Computer Interfaces
Verified
Journal Article
Open access
FKFabian Kohler
Fabian Kohler
CGC. Alexis Gkogkidis
C. Alexis Gkogkidis
CBChristian Bentler
Christian Bentler
XWXi Wang
Xi Wang
MGMortimer Gierthmuehlen
Mortimer Gierthmuehlen
MSMartin Schuettler
Martin Schuettler
Wireless implants for interaction with the cortex have developed rapidly over the last decade and increasingly meet demands of clinical brain–computer interfaces. For such applications, well-established technologies are available, suitable for recording of neural activity at different spatial scales and adequate for modulating brain activity by cortical electrical stimulation. The incorporation of recording and stimulation into closed-loop systems is a major aim in active, fully implantable medical device design. To reduce clinical long-term implantation risk and to increase the spatial specificity of epicortical recordings and stimulation, micro-electrocorticography is a promising technology. However, currently there is a lack of implants suitable for chronic human clinical applications that utilize micro-electrocorticography and possess closed-loop functionality. Here, we describe the clinical importance of cortical stimulation, give an overview of existing implants that use mainly epicortical recording methods, and present results of a closed-loop micro-electrocorticography system developed for clinical application within a collaborative framework. Finally, we conclude with our vision of future design options in the field of neuroprosthetic devices.

19 November 2015 in Hypertension Research
Verified
Journal Article
Closed access
MGMortimer Gierthmuehlen
Mortimer Gierthmuehlen
DPDennis T T Plachta
Dennis T T Plachta

23 May 2014 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
MGMortimer Gierthmuehlen
Mortimer Gierthmuehlen
XWXi Wang
Xi Wang
AGAlexis Gkogkidis
Alexis Gkogkidis
CHChristian Henle
Christian Henle
JFJoerg Fischer
Joerg Fischer
TBTonio Ball
Tonio Ball

2 June 2011 in Epilepsia
Verified
Journal Article
Open access
PDF file
FVFlorian Volz
Florian Volz
HBHans H. Bock
Hans H. Bock
MGMortimer Gierthmuehlen
Mortimer Gierthmuehlen
JZJosef Zentner
Josef Zentner
CHCarola A. Haas
Carola A. Haas
TFThomas M. Freiman
Thomas M. Freiman
Purpose: Hippocampal mossy cells receive dense innervation from dentate granule cells and, in turn, mossy cells innervate both granule cells and interneurons. Mossy cell loss is thought to trigger granule cell mossy fiber sprouting, which may affect granule cell excitability. The aim of this study was to quantify mossy cell loss in two animal models of temporal lobe epilepsy, and determine whether there exists a relationship between mossy cell loss, mossy fiber sprouting, and granule cell dispersion. Methods: Representative hippocampal sections from p35 knockout mice and mice with unilateral intrahippocampal kainate injection were immunolabeled for GluR2/3, two subunits of the amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor and calretinin to identify mossy cells. Mossy fibers were immunostained against synaptoporin. Key Findings: p35 Knockout mice showed no hilar cell death, but moderate mossy fiber sprouting and granule cell dispersion. In the kainate-injected hippocampus, there was an 80% and 85% reduction of GluR2/3- and GluR2/3/calretinin-positive hilar neurons, respectively, and dense mossy fiber sprouting and significant granule cell dispersion. In the contralateral hippocampus there was a 52% loss of GluR2/3-, but only a 20% loss of GluR2/3-calretinin-immunoreactive presumptive mossy cells, and granule cell dispersion; no mossy fiber sprouting was observed. Significance: These results indicate a probable lack of causality between mossy cell death and mossy fiber sprouting.